Fox Chase Cancer Center

2026–2027 · award

Regulation of KRAS expression in PDAC via promoter DNA structural dynamics

Amy Whitaker · Fox Chase Cancer Center · funded by American Cancer Society

150k

2026–2028 · award

Development and Use of a Ras-GAP Glue in NF1

Jonathan Chernoff · Fox Chase Cancer Center · funded by Children's Tumor Foundation

200kNeurofibromatosis and Schwannoma Cases

2026 · facilities

ProteinLigand Crystallography as a Feedback Engine for Computational Drug Discovery

Sven Miller · Fox Chase Cancer Center · funded by U.S. Department of Energy

2025–2027 · award

The role of pathogenic PALB2 mutations in breast cancer and mechanisms of chemoresistance

Wei-Ting Yueh · Fox Chase Cancer Center · funded by American Cancer Society

217.5kPARP inhibition in cancer therapy

2025–2027 · award

Impact of Folic Acid Supplementation on the Induction of Colitis-associated Colon Tumorigenesis

Ariane Rocha Bartolomeu · Fox Chase Cancer Center · funded by American Cancer Society

217.5kFolate and B Vitamins Research

2025–2028 · award

Geospatial Assessment of the Role of Exposome in Early Age at Onset Adult Cancers

Shannon Lynch · Fox Chase Cancer Center · funded by American Cancer Society

946kHealth, Environment, Cognitive Aging

2025 · fellowship · AACR-Incyte Immuno-oncology Research Fellowship

Targeting BCL2 and Mitophagy to Enhance the Immunostimulatory Effects of Radiation in Breast Cancer

Emma Guilbaud · Fox Chase Cancer Center · funded by American Association for Cancer Research

2025 · career development · Young Investigator Award

Mediators and Biomarkers for Cellular Immunity Response in the Treatment of Checkpoint Inhibitor Immunotherapy Related Adverse Events

Joseph Van Galen · Fox Chase Cancer Center · funded by Conquer Cancer Foundation

$50k

2025–2027 · research · R21

Assessment of Efficacy and Toxicity of T3 for Medulloblastoma Treatment

Zeng-Jie Yang · Fox Chase Cancer Center · funded by National Institutes of Health

$219.4k

2025–2027 · research · R21

Targeting p300/CBP in renal cell carcinoma

Vladimir M Kolenko · Fox Chase Cancer Center · funded by National Institutes of Health

$483.4k

2025–2030 · research · R37

Regulation of hematopoiesis by ribosomal protein paralogs

David L. Wiest · Fox Chase Cancer Center · funded by National Institutes of Health

$690.7k

2025–2027 · research · R21

Exploring the Neuroprotective Potential of CBD in Preventing Oxaliplatin-Induced Neuropathy: A Prospective Study

Namrata Vijayvergia · Fox Chase Cancer Center · funded by National Institutes of Health

$429.2k

2025–2030 · research · R01

Thyroid Hormone Inhibits Medulloblastoma Growth by Inducing Tumor Cell Differentiation

Zeng-Jie Yang · Fox Chase Cancer Center · funded by National Institutes of Health

$559.6k

2025–2027 · research · R03

Pilot Studies of NN-01-195, a New Tumor-Targeted AURKA Inhibitor

Erica A. Golemis · Fox Chase Cancer Center · funded by National Institutes of Health

$186k

2025–2030 · research · R01

Targeting anoctamin 6 to disrupt trogocytosis of cancer-associated fibroblasts

Igor Astsaturov · Fox Chase Cancer Center · funded by National Institutes of Health

$642.8k

2024–2029 · research · R35

Interplay between DNA base excision repair and transcriptional regulation

Amy Michelle Whitaker · Fox Chase Cancer Center · funded by National Institutes of Health

$470kDNA and Nucleic Acid Chemistry

2024–2026 · research · R21

Estrogen Suppression as a Strategy to Enhance Immunotherapy Efficacy in EGFR-Mutated Non-Small Cell Lung Cancer

Joseph Nicholas Bodor · Fox Chase Cancer Center · funded by National Institutes of Health

$483.4k

2024–2029 · research · R35

Mechanistic Studies of Genome Folding

Yu Liu · Fox Chase Cancer Center · funded by National Institutes of Health

$470kGenomics and Chromatin Dynamics

2024–2029 · research · R37

Targeting DHX9 to trigger viral mimicry and immunotherapy responsiveness in Small Cell Lung Cancer (SCLC)

Israel Canadas · Fox Chase Cancer Center · funded by National Institutes of Health

$649.7kinterferon and immune responses

2024–2027 · research · R00

Defining the molecular basis controlling hematopoietic stem cell symmetric and asymmetric divisions

Hanzhi Luo · Fox Chase Cancer Center · funded by National Institutes of Health

$249k

2024–2027 · award

The role of aging in immune-regulated reactivation from metastatic melanoma

Mitchell Fane · Fox Chase Cancer Center · funded by Melanoma Research Alliance

255kPhagocytosis and Immune Regulation

2024–2029 · research · R01

Promoting Effective Clinical Communication about Sexual Health after Gynecologic Cancer: A Randomized Controlled Trial of a Patient-Focused Intervention

Jennifer Barsky Reese · Fox Chase Cancer Center · funded by National Institutes of Health

$475.3kCancer survivorship and care

2024–2029 · research · R01

Interrogating MRCK Protein Kinases in Ovarian Cancer

James Stuart Duncan · Fox Chase Cancer Center · funded by National Institutes of Health

$235k

2024–2026 · research · R25

Addressing the Training Gap in Oncology on Sexual Health: Development of the Sexual Health Integrative Fellowship Training (SHIFT) Course for Hematology-Oncology Fellows

Jennifer Barsky Reese · Fox Chase Cancer Center · funded by National Institutes of Health

$162kCancer survivorship and care

2024–2029 · research · R01

Interrogating MRCK Protein Kinases in Ovarian Cancer

James Stuart Duncan · Fox Chase Cancer Center · funded by National Institutes of Health

$451.9k

2024–2026 · research · R21

A novel engineered IL-21-based immunocytokine as a therapeutic approach for tumor targeting in renal cancer

Petr B. Makhov · Fox Chase Cancer Center · funded by National Institutes of Health

$483.4k

2024–2026 · research · R21

NPC1 as a novel therapeutic target in ccRCC

Vladimir M Kolenko · Fox Chase Cancer Center · funded by National Institutes of Health

$219.7kCancer, Lipids, and Metabolism

2024–2029 · research · R01

Hepatic Tissue Integrity and Clonal Fitness: Key Factors in Controlling β-Catenin Induced Oncogenesis

Joan Font-Burgada · Fox Chase Cancer Center · funded by National Institutes of Health

$601.9kWnt/β-catenin signaling in development and cancer

2024–2028 · award

Enabling the best minds to tackle the pancreatic cancer microenvironment

Edna Cukierman · Fox Chase Cancer Center · funded by American Cancer Society

400k

2024–2029 · contract · N01

TO Title: Contract Orientation & Kickoff Meeting for Preclinical Services for PREVENT Base IDIQ Title: PREVENT Cancer Preclinical Drug Development Program: Preclinical Efficacy and Intermediate E

Margie L. Clapper · Fox Chase Cancer Center · funded by National Institutes of Health

$3 500

2024–2029 · research · R01

Interrogating MRCK Protein Kinases in Ovarian Cancer

James Stuart Duncan · Fox Chase Cancer Center · funded by National Institutes of Health

$451.9k

2024–2026 · research · R25

Addressing the Training Gap in Oncology on Sexual Health: Development of the Sexual Health Integrative Fellowship Training (SHIFT) Course for Hematology-Oncology Fellows

Jennifer Barsky Reese · Fox Chase Cancer Center · funded by National Institutes of Health

$161.3k

2024–2029 · research · R37

Targeting DHX9 to trigger viral mimicry and immunotherapy responsiveness in Small Cell Lung Cancer (SCLC)

Israel Canadas · Fox Chase Cancer Center · funded by National Institutes of Health

$649.7k

2024–2029 · research · R35

Mechanistic Studies of Genome Folding

Yu Liu · Fox Chase Cancer Center · funded by National Institutes of Health

$470k

2024–2027 · research · R21

NPC1 as a novel therapeutic target in ccRCC

Vladimir M Kolenko · Fox Chase Cancer Center · funded by National Institutes of Health

$263.7k

2024–2029 · research · R01

Promoting Effective Clinical Communication about Sexual Health after Gynecologic Cancer: A Randomized Controlled Trial of a Patient-Focused Intervention

Jennifer Barsky Reese · Fox Chase Cancer Center · funded by National Institutes of Health

$488.6k

2024–2027 · research · R00

Defining the molecular basis controlling hematopoietic stem cell symmetric and asymmetric divisions

Hanzhi Luo · Fox Chase Cancer Center · funded by National Institutes of Health

$249k

2024–2029 · research · R35

Interplay between DNA base excision repair and transcriptional regulation

Amy Michelle Whitaker · Fox Chase Cancer Center · funded by National Institutes of Health

$470k

2024–2028 · research · R01

Hepatic Tissue Integrity and Clonal Fitness: Key Factors in Controlling β-Catenin Induced Oncogenesis

Joan Font-Burgada · Fox Chase Cancer Center · funded by National Institutes of Health

$531.7k

2024–2025 · research · R13

ThymUS 2025 International Conference on Lymphopoiesis

David L. Wiest · Fox Chase Cancer Center · funded by National Institutes of Health

$3 200